Cargando…
Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2015
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315270/ http://dx.doi.org/10.1186/1479-5876-13-S1-O6 |
| _version_ | 1782355448938102784 |
|---|---|
| author | Long, Georgina V Atkinson, Victoria Ascierto, Paolo A Brady, Benjamin Dutriaux, Caroline Maio, Michele Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Schmidt, Henrik Schadendorf, Dirk Gogas, Helen Horak, Christine Sharkey, Brian Waxman, Ian M Robert, Caroline |
| author_facet | Long, Georgina V Atkinson, Victoria Ascierto, Paolo A Brady, Benjamin Dutriaux, Caroline Maio, Michele Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Schmidt, Henrik Schadendorf, Dirk Gogas, Helen Horak, Christine Sharkey, Brian Waxman, Ian M Robert, Caroline |
| author_sort | Long, Georgina V |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4315270 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2015 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-43152702015-02-12 Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma Long, Georgina V Atkinson, Victoria Ascierto, Paolo A Brady, Benjamin Dutriaux, Caroline Maio, Michele Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Schmidt, Henrik Schadendorf, Dirk Gogas, Helen Horak, Christine Sharkey, Brian Waxman, Ian M Robert, Caroline J Transl Med Oral Presentation BioMed Central 2015-01-15 /pmc/articles/PMC4315270/ http://dx.doi.org/10.1186/1479-5876-13-S1-O6 Text en Copyright © 2015 Long et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
| spellingShingle | Oral Presentation Long, Georgina V Atkinson, Victoria Ascierto, Paolo A Brady, Benjamin Dutriaux, Caroline Maio, Michele Mortier, Laurent Hassel, Jessica C Rutkowski, Piotr McNeil, Catriona Kalinka-Warzocha, Ewa Savage, Kerry J Hernberg, Micaela Lebbé, Celeste Charles, Julie Mihalcioiu, Catalin Chiarion-Sileni, Vanna Mauch, Cornelia Schmidt, Henrik Schadendorf, Dirk Gogas, Helen Horak, Christine Sharkey, Brian Waxman, Ian M Robert, Caroline Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title | Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title_full | Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title_fullStr | Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title_full_unstemmed | Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title_short | Nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| title_sort | nivolumab improved survival vs dacarbazine in patients with untreated advanced melanoma |
| topic | Oral Presentation |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315270/ http://dx.doi.org/10.1186/1479-5876-13-S1-O6 |
| work_keys_str_mv | AT longgeorginav nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT atkinsonvictoria nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT asciertopaoloa nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT bradybenjamin nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT dutriauxcaroline nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT maiomichele nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT mortierlaurent nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT hasseljessicac nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT rutkowskipiotr nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT mcneilcatriona nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT kalinkawarzochaewa nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT savagekerryj nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT hernbergmicaela nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT lebbeceleste nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT charlesjulie nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT mihalcioiucatalin nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT chiarionsilenivanna nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT mauchcornelia nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT schmidthenrik nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT schadendorfdirk nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT gogashelen nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT horakchristine nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT sharkeybrian nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT waxmanianm nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma AT robertcaroline nivolumabimprovedsurvivalvsdacarbazineinpatientswithuntreatedadvancedmelanoma |